| Date | Quarter | Session | EPS (est → actual) | Revenue (est → actual) |
|---|---|---|---|---|
| Oct 21, 2026Next | Q3 2026 | Before market open | 2.32 | 11.5 B |
Sep 1, 2026
Philip Morris has transformed from a declining tobacco play into a higher-margin, smoke-free growth story. Here's why I'm changing my mind on PM.
STAMFORD, CT, September 01, 2026--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of a fireside chat session with Jacek Olczak, Group CEO PMI, at the 2026 Barclays Global Consumer Conference on Tuesday, September 8, 2026, at approximately 9:45 a.m. ET. The webcast can be accessed here. An archived copy of the webcast will be available for six months post-event on the same page.
Philip Morris has surpassed the broader consumer staples sector over the past year, and analysts remain moderately optimistic about the stock’s prospects.
Aug 27, 2026
MO and PM advance their smoke-free strategies as each leverages portfolio strength, innovation and pricing in a shifting tobacco market.
Aug 25, 2026
MO's PM manufacturing deal targets greater tobacco efficiency, supporting investment as cigarette volumes remain under pressure.
Philip Morris Buy: premium pricing power, IQOS & ZYN driving 41%+ smoke-free revenue, and strong FCF/dividend growth. Click for more on PM stock.
Altria Group, Inc. (NYSE:MO) and Philip Morris International Inc. (NYSE:PM) have entered into reciprocal contract manufacturing arrangements designed to improve manufacturing efficiency and expand their operational flexibility. The first shipments are expected in 2027, while both companies said the agreements are not expected to have a material impact on their 2026 results. The deal is […]
Aug 24, 2026
Philip Morris stock rallies on a strategic agreement with Altria. Here's what makes PM shares worth owning in the back half of 2026.
PM's FDA authorization for 11 ZYN ULTRA nicotine pouches expands its U.S. smoke-free portfolio and supports the long-term transformation.
STAMFORD, CT, August 24, 2026--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announced that it has entered, through its non-U.S. affiliates, into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria (NYSE:MO).
RICHMOND, Va., August 24, 2026--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
Altria and Philip Morris International enter a contract manufacturing deal to strengthen operating capabilities.
Aug 23, 2026
Earlier this week, Philip Morris International reported past Q2 2026 results with year-on-year growth in both revenue and net income, while its affiliate Swedish Match USA received FDA Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. This combination of stronger earnings and expanded FDA-authorized smoke-free products highlights how Philip Morris International is deepening its shift away from combustible...
Aug 22, 2026
Philip Morris International stock has delivered a strong 132.9% return over the past five years, while the latest Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a 17.3% discount to that valuation. However, the broader checks still flag the stock as only a limited-value opportunity. Recent attention around nicotine pouches, including new U.S. regulatory approvals, adds a fresh layer for investors weighing what that mix really means for pricing today. Over...
Philip Morris International (PM) drew fresh attention after the U.S. Food and Drug Administration granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products sold by its affiliate Swedish Match USA. See our latest analysis for Philip Morris International. At a share price of US$188.23, Philip Morris International has seen short term share price weakness, with the 30 day share price return declining 3.12%, while its year to date share price return of 17.42% and five...
The fair value estimate for Philip Morris International has been updated from US$193.14 to US$203.80, indicating a slightly higher implied price target range. That change is consistent with recent analyst commentary that considers ongoing IQOS and ZYN execution, the resilience of combustibles, and mixed views on 2026 risks and currency pressure. Read on to see how this evolving narrative could influence your view of Philip Morris International and how to track future developments in the...
Aug 21, 2026
STAMFORD, CT, August 21, 2026--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review.
